Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABT

Are Medical Device Stocks Good Investments During a Recession?

The stock market has witnessed a massive sell-off lately on concerns over the Fed’s aggressive interest rate hikes to fight the decade-high inflation. Many analysts expect the economy to slip into recession due to the Fed’s monetary policy tightening. Since the medical device industry is known to be one of…

StockNews.com

Former ballerina Susan Jaffe to lead American Ballet Theatre

American Ballet Theatre has named its first new artistic director in 30 years

The Independent UK

3 Mega-Cap Stocks You'll Regret Not Buying on the Dip

The Fed's plan to raise interest rates aggressively has aggravated bearish investor sentiment ahead of the Federal Reserve Board meeting this week. And rising recessionary fears are expected to sustain the bearish mood in the near term. However, quality mega-cap stocks Abbott (ABT), Broadcom (AVGO), and Pfizer (PFE) are expected…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Rast explains "difficult" DTM return that yielded no points

Three-time DTM champion Rene Rast said there was nothing he could do to break into the points after qualifying mid-pack for the second race of his category return in Portimao.

Autosport

Rast laments "difficult" Portimao weekend after point-less DTM return

Factory Audi driver Rene Rast felt there was nothing he could do to escape the train of cars and score some points in the second race of the Portimao season opener.

Motorsport

3 Large-Cap Stocks Rated 'Strong Buy' to Snatch-Up in May

Since the persistent Ukraine-Russia war, rising inflationary pressures, and Fed's upcoming interest rate hikes are expected to keep the stock market volatile in the near term, investors seek opportunities to invest in large-cap stocks, which hold the potential to generate relatively stable returns. So, we think it could be wise…

StockNews.com

Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 8.78% on an annualized basis producing an average annual return of 20.13%. Currently, Abbott Laboratories has a market capitalization of $196.98 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

DTM Portimao: Muller takes dominant win for Audi

Audi driver Nico Muller led the second DTM race at Portimao from start to finish to take a convincing victory, as Red Bull’s Felipe Fraga scored his maiden podium in the series.

Autosport

Portimao DTM: Muller takes dominant Sunday win for Audi

Audi driver Nico Muller led the second DTM race at Portimao from start to finish to take a convincing victory, as Red Bull’s Felipe Fraga scored his maiden podium in the series.

Motorsport

DTM Portimao: Auer leads Mercedes 1-2 as slow restart dents Bortolotti's charge

Mercedes driver Lucas Auer claimed victory in a dramatic opening race of the 2022 season at Portimao, taking advantage of a slow restart from polesitter Mirko Bortolotti.

Autosport

Audi RS Q8 Signature Edition By ABT Gets 790 HP And All The Carbon Fiber

Limited to 96 units, the 196-mph SUV costs a wallet-wreaking €316,480.

Motor1

Porsche's Olsen tops final day of Portimao DTM testing

Dennis Olsen put Porsche on top on the final day of DTM pre-season testing at Portimao, beating the Audi of 10-time race winner Nico Muller.

Autosport

Porsche tops final day of Portimao DTM testing

Dennis Olsen put Porsche on top on the final day of DTM pre-season testing at Portimao, beating the Audi of 10-time race winner Nico Muller.

Motorsport

What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings

Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically, with Nutrition growing 8%

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Autosport

Van der Linde faces "difficult situation" with Rast's DTM return

Kelvin van der Linde faces a “difficult situation” to remain the top dog within the Abt Audi DTM team this season with the arrival of Rene Rast, reckons 2013 champion Mike Rockenfeller.

Benzinga

Abbott Clocks Q1 COVID-19 Test Sales Of $3.3B, Reaffirms FY22 EPS Outlook

Abbott Laboratories (NYSE:ABT) has reported Q1 FY22 adjusted EPS of $1.73, up 31.1% Y/Y, better than the consensus of $1.47 and the management guidance of $1.50. Q1 sales of $11.9 billion increased 13.8% on a reported basis and 17.5% on an organic basis, beating the consensus of $11.02 billion. Worldwide sales, excluding…

StockNews.com

5 Ultra-Safe Dividend Aristocrats to Buy in a Market Downturn

Worries over intensifying supply disruptions with growing sanctions on Russia have shaken investors. Furthermore, rising crude oil prices coupled with record-high inflation have given rise to recession fears. Thus, we think it could be wise to bet on ultra-safe dividend aristocrats Johnson & Johnson (JNJ), Walmart (WMT), PepsiCo (PEP), Abbott…

Benzinga

Abbott Laboratories: Q1 Earnings Insights

Abbott Laboratories (NYSE:ABT) reported its Q1 earnings results on Wednesday, April 20, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

If You Invested $1000 In Abbott Laboratories 5 Years Ago, Here's How Much You Would Have Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 8.67% on an annualized basis producing an average annual return of 21.94%. Currently, Abbott Laboratories has a market capitalization of $209.78 billion.

Benzinga

Earnings Preview: Abbott Laboratories

Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-04-20. Here's what investors need to know before the announcement. Analysts estimate that Abbott Laboratories will report an earnings per share (EPS) of $1.47.

StockNews.com

Abbott Laboratories vs. Zimmer Biomet Holdings: Which Medical Device Stock is a Better Buy?

The medical devices industry is thriving and the integration of advanced technologies position the industry well for growth. Therefore, prominent players in this space, Abbott Laboratories (ABT) and Zimmer Biomet Holdings (ZBH), should benefit. But which of these stocks is a better buy now? Read more to find out.

Benzinga

Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings

Raymond James has outlined its expectations for next week when Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), and Intuitive Surgical Inc (NASDAQ:ISRG) will report Q1 FY22 earnings. Analysts believe that the Med Tech investors have become somewhat 'paralyzed' given the macro/factor-driven concerns. On the macro, investor attention seems to be focused less on revenue growth and more…

StockNews.com

5 Top Mega-Cap Stocks in the Healthcare Sector to Buy This Month

The healthcare sector is known for its defensive qualities. Therefore, betting on mega-cap healthcare stocks could be one of the best ways to generate stable returns amid the current, extended, market volatility. We think their solid growth attributes and profit margins make the stocks of Novartis (NVS), Danaher (DHR), Eli…

Benzinga

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.51% on an annualized basis producing an average annual return of 15.1%. Currently, Abbott Laboratories has a market capitalization of $211.63 billion.

Motor1

Audi RS6 Avant Tactical Green With ABT Mods Borders On Perfection

Wagons are boring? Think again.

1 … 11 12 13 14

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.